225 related articles for article (PubMed ID: 29774413)
21. Histone Deacetylase Inhibitor Induced Radiation Sensitization Effects on Human Cancer Cells after Photon and Hadron Radiation Exposure.
Gerelchuluun A; Maeda J; Manabe E; Brents CA; Sakae T; Fujimori A; Chen DJ; Tsuboi K; Kato TA
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414878
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
23. Altering histone acetylation status in donor cells with suberoylanilide hydroxamic acid does not affect dog cloning efficiency.
Kim MJ; Oh HJ; Kim GA; Suh HN; Jo YK; Choi YB; Kim DH; Han HJ; Lee BC
Theriogenology; 2015 Oct; 84(7):1256-61. PubMed ID: 26259535
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage.
Conti C; Leo E; Eichler GS; Sordet O; Martin MM; Fan A; Aladjem MI; Pommier Y
Cancer Res; 2010 Jun; 70(11):4470-80. PubMed ID: 20460513
[TBL] [Abstract][Full Text] [Related]
25. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
26. Modulation of radiation response by histone deacetylase inhibition.
Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of monomethylarsonous acid (MMA(III))-induced cell malignant transformation through restoring dysregulated histone acetylation.
Ge Y; Gong Z; Olson JR; Xu P; Buck MJ; Ren X
Toxicology; 2013 Oct; 312():30-5. PubMed ID: 23891734
[TBL] [Abstract][Full Text] [Related]
28. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
[TBL] [Abstract][Full Text] [Related]
29. ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.
Wu JC; Jiang HM; Yang XH; Zheng HC
Cancer Med; 2018 Sep; 7(9):4554-4569. PubMed ID: 30091530
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.
Li Y; Liu B; Zhao H; Sailhamer EA; Fukudome EY; Zhang X; Kheirbek T; Finkelstein RA; Velmahos GC; deMoya M; Hales CA; Alam HB
Shock; 2009 Nov; 32(5):517-23. PubMed ID: 19295477
[TBL] [Abstract][Full Text] [Related]
31. Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry.
Krautkramer KA; Reiter L; Denu JM; Dowell JA
J Proteome Res; 2015 Aug; 14(8):3252-62. PubMed ID: 26120868
[TBL] [Abstract][Full Text] [Related]
32. Targeting histones for degradation in cancer cells as a novel strategy in cancer treatment.
Yin Y; Zhu Q; Jiang T; Fan L; Qiu X
Sci China Life Sci; 2019 Aug; 62(8):1078-1086. PubMed ID: 30465232
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells.
Dudakovic A; Camilleri ET; Lewallen EA; McGee-Lawrence ME; Riester SM; Kakar S; Montecino M; Stein GS; Ryoo HM; Dietz AB; Westendorf JJ; van Wijnen AJ
J Cell Physiol; 2015 Jan; 230(1):52-62. PubMed ID: 24912092
[TBL] [Abstract][Full Text] [Related]
34. Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A.
Kypreou KP; Sourlingas TG; Sekeri-Pataryas KE
Exp Gerontol; 2004 Apr; 39(4):469-79. PubMed ID: 15050280
[TBL] [Abstract][Full Text] [Related]
35. The repair of gamma-radiation-induced DNA damage is inhibited by microcystin-LR, the PP1 and PP2A phosphatase inhibitor.
Lankoff A; Bialczyk J; Dziga D; Carmichael WW; Gradzka I; Lisowska H; Kuszewski T; Gozdz S; Piorun I; Wojcik A
Mutagenesis; 2006 Jan; 21(1):83-90. PubMed ID: 16434448
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
[TBL] [Abstract][Full Text] [Related]
37. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
38. Histone Deacetylase Inhibitor SAHA Improves High Salinity Tolerance Associated with Hyperacetylation-Enhancing Expression of Ion Homeostasis-Related Genes in Cotton.
He S; Hao Y; Zhang Q; Zhang P; Ji F; Cheng H; Lv D; Sun Y; Hao F; Miao C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993126
[TBL] [Abstract][Full Text] [Related]
39. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]